Your browser doesn't support javascript.
loading
The influence of risk factors on the onset and outcome of psychosis: What we learned from the GAP study.
Murray, R M; Mondelli, V; Stilo, S A; Trotta, A; Sideli, L; Ajnakina, O; Ferraro, L; Vassos, E; Iyegbe, C; Schoeler, T; Bhattacharyya, S; Marques, T R; Dazzan, P; Lopez-Morinigo, J; Colizzi, M; O'Connor, J; Falcone, M A; Quattrone, D; Rodriguez, V; Tripoli, G; La Barbera, D; La Cascia, C; Alameda, L; Trotta, G; Morgan, C; Gaughran, F; David, A; Di Forti, M.
Afiliação
  • Murray RM; Institute of Psychiatry, Psychology and Neuroscience, Department of Psychosis Studies, King's College London, London, UK; Department of Experimental Biomedicine and Clinical Neuroscience, University of Palermo, Palermo, Italy. Electronic address: robin.murray@kcl.ac.uk.
  • Mondelli V; Institute of Psychiatry, Psychology and Neuroscience, Department of Psychosis Studies, King's College London, London, UK.
  • Stilo SA; Institute of Psychiatry, Psychology and Neuroscience, Department of Psychosis Studies, King's College London, London, UK; Division of Psychology and Language Sciences, University College London, London, UK.
  • Trotta A; Institute of Psychiatry, Psychology and Neuroscience, Department of Psychosis Studies, King's College London, London, UK.
  • Sideli L; Institute of Psychiatry, Psychology and Neuroscience, Department of Psychosis Studies, King's College London, London, UK; Department of Experimental Biomedicine and Clinical Neuroscience, University of Palermo, Palermo, Italy.
  • Ajnakina O; Institute of Psychiatry, Psychology and Neuroscience, Department of Psychosis Studies, King's College London, London, UK.
  • Ferraro L; Department of Experimental Biomedicine and Clinical Neuroscience, University of Palermo, Palermo, Italy.
  • Vassos E; Institute of Psychiatry, Psychology and Neuroscience, Department of Psychosis Studies, King's College London, London, UK.
  • Iyegbe C; Institute of Psychiatry, Psychology and Neuroscience, Department of Psychosis Studies, King's College London, London, UK.
  • Schoeler T; Institute of Psychiatry, Psychology and Neuroscience, Department of Psychosis Studies, King's College London, London, UK; Department of Psychiatry, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
  • Bhattacharyya S; Institute of Psychiatry, Psychology and Neuroscience, Department of Psychosis Studies, King's College London, London, UK.
  • Marques TR; Institute of Psychiatry, Psychology and Neuroscience, Department of Psychosis Studies, King's College London, London, UK.
  • Dazzan P; Institute of Psychiatry, Psychology and Neuroscience, Department of Psychosis Studies, King's College London, London, UK.
  • Lopez-Morinigo J; Institute of Psychiatry, Psychology and Neuroscience, Department of Psychosis Studies, King's College London, London, UK; Department of Psychiatry, Universidad Autónoma de Madrid, Madrid, Spain.
  • Colizzi M; Institute of Psychiatry, Psychology and Neuroscience, Department of Psychosis Studies, King's College London, London, UK.
  • O'Connor J; Institute of Psychiatry, Psychology and Neuroscience, Department of Psychosis Studies, King's College London, London, UK; Department of Neuropsychology, Royal Free London NHS Foundation Trust, Royal Free Hospital, London, UK.
  • Falcone MA; Institute of Psychiatry, Psychology and Neuroscience, Department of Psychosis Studies, King's College London, London, UK.
  • Quattrone D; Institute of Psychiatry, Psychology and Neuroscience, Department of Psychosis Studies, King's College London, London, UK.
  • Rodriguez V; Institute of Psychiatry, Psychology and Neuroscience, Department of Psychosis Studies, King's College London, London, UK.
  • Tripoli G; Institute of Psychiatry, Psychology and Neuroscience, Department of Psychosis Studies, King's College London, London, UK; Department of Experimental Biomedicine and Clinical Neuroscience, University of Palermo, Palermo, Italy.
  • La Barbera D; Department of Experimental Biomedicine and Clinical Neuroscience, University of Palermo, Palermo, Italy.
  • La Cascia C; Department of Experimental Biomedicine and Clinical Neuroscience, University of Palermo, Palermo, Italy.
  • Alameda L; Institute of Psychiatry, Psychology and Neuroscience, Department of Psychosis Studies, King's College London, London, UK.
  • Trotta G; Institute of Psychiatry, Psychology and Neuroscience, Department of Psychosis Studies, King's College London, London, UK; Department of Medicine and Surgery, University of Milano Bicocca, Monza, Italy.
  • Morgan C; Institute of Psychiatry, Psychology and Neuroscience, Department of Psychosis Studies, King's College London, London, UK.
  • Gaughran F; Institute of Psychiatry, Psychology and Neuroscience, Department of Psychosis Studies, King's College London, London, UK.
  • David A; Institute of Psychiatry, Psychology and Neuroscience, Department of Psychosis Studies, King's College London, London, UK; Institute of Mental Health, University College London, London, UK.
  • Di Forti M; Institute of Psychiatry, Psychology and Neuroscience, Department of Psychosis Studies, King's College London, London, UK; Department of Experimental Biomedicine and Clinical Neuroscience, University of Palermo, Palermo, Italy.
Schizophr Res ; 225: 63-68, 2020 11.
Article em En | MEDLINE | ID: mdl-32037203
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 8_ODS3_consumo_sustancias_psicoactivas Problema de saúde: 8_cannabis_related_disorders / 8_cocaine_other_stimulant_related_disorders Assunto principal: Transtornos Psicóticos / Sistema Hipotálamo-Hipofisário Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans País/Região como assunto: Europa Idioma: En Revista: Schizophr Res Assunto da revista: PSIQUIATRIA Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 8_ODS3_consumo_sustancias_psicoactivas Problema de saúde: 8_cannabis_related_disorders / 8_cocaine_other_stimulant_related_disorders Assunto principal: Transtornos Psicóticos / Sistema Hipotálamo-Hipofisário Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans País/Região como assunto: Europa Idioma: En Revista: Schizophr Res Assunto da revista: PSIQUIATRIA Ano de publicação: 2020 Tipo de documento: Article